Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia

doi:10.1002/ajh.24832

. 2017 Jun 22:10.1002/ajh.24832.

doi: 10.1002/ajh.24832. Online ahead of print.

Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia

Raj S Kasthuri¹, Megan Montifar², Jeffrey Nelson³, Helen Kim^{3

4}, Michael T Lawton⁵, Marie E Faughnan^{2

6}; Brain Vascular Malformation Consortium HHT Investigator Group⁷

Collaborators, Affiliations

Collaborators

Brain Vascular Malformation Consortium HHT Investigator Group:
Murali Chakinala, Marianne S Clancy, Marie E Faughnan, James R Gossage, Katherine Henderson, Vivek Iyer, Raj S Kasthuri, Helen Kim, Timo Krings, Michael T Lawton, Doris Lin, Hans-Jurgen Mager, Justin P McWilliams, Jamie McDonald, Ludmila Pawlikowska, Jeffrey Pollak, Felix Ratjen, Karen Swanson, Karel terBrugge, Dilini Vethanayagam, Andrew White, Robert I White Jr, Pearce Wilcox, William L Young

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
² Division of Respirology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Canada.
³ Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, California.
⁴ Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California.
⁵ Department of Neurological Surgery, University of California at San Francisco, San Francisco, California.
⁶ Li Ka Shing Knowledge Institute, Toronto, Canada.
⁷ Brain Vascular Malformation Consortium HHT Investigator Group.

PMID: 28639385
PMCID: PMC5997494
DOI: 10.1002/ajh.24832

Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia

Raj S Kasthuri et al. Am J Hematol. 2017.

. 2017 Jun 22:10.1002/ajh.24832.

doi: 10.1002/ajh.24832. Online ahead of print.

Authors

Raj S Kasthuri¹, Megan Montifar², Jeffrey Nelson³, Helen Kim^{3

4}, Michael T Lawton⁵, Marie E Faughnan^{2

6}; Brain Vascular Malformation Consortium HHT Investigator Group⁷

Collaborators

Brain Vascular Malformation Consortium HHT Investigator Group:
Murali Chakinala, Marianne S Clancy, Marie E Faughnan, James R Gossage, Katherine Henderson, Vivek Iyer, Raj S Kasthuri, Helen Kim, Timo Krings, Michael T Lawton, Doris Lin, Hans-Jurgen Mager, Justin P McWilliams, Jamie McDonald, Ludmila Pawlikowska, Jeffrey Pollak, Felix Ratjen, Karen Swanson, Karel terBrugge, Dilini Vethanayagam, Andrew White, Robert I White Jr, Pearce Wilcox, William L Young

Affiliations

¹ Division of Hematology and Oncology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
² Division of Respirology, Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, Canada.
³ Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California at San Francisco, San Francisco, California.
⁴ Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, California.
⁵ Department of Neurological Surgery, University of California at San Francisco, San Francisco, California.
⁶ Li Ka Shing Knowledge Institute, Toronto, Canada.
⁷ Brain Vascular Malformation Consortium HHT Investigator Group.

PMID: 28639385
PMCID: PMC5997494
DOI: 10.1002/ajh.24832

No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosure of Conflicts of Interest

The authors do not have any relevant conflicts of interest to report.

Cited by

Weekly epistaxis duration as an indicator of epistaxis severity in hereditary hemorrhagic telangiectasia-Preliminary results from a randomized controlled trial.
Wu V, Lee JM, Vozoris NT, Faughnan ME. Wu V, et al. Laryngoscope Investig Otolaryngol. 2021 Apr 8;6(3):370-375. doi: 10.1002/lio2.561. eCollection 2021 Jun. Laryngoscope Investig Otolaryngol. 2021. PMID: 34195356 Free PMC article.
An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.
Al-Samkari H, Kasthuri RS, Parambil JG, Albitar HA, Almodallal YA, Vázquez C, Serra MM, Dupuis-Girod S, Wilsen CB, McWilliams JP, Fountain EH, Gossage JR, Weiss CR, Latif MA, Issachar A, Mei-Zahav M, Meek ME, Conrad M, Rodriguez-Lopez J, Kuter DJ, Iyer VN. Al-Samkari H, et al. Haematologica. 2021 Aug 1;106(8):2161-2169. doi: 10.3324/haematol.2020.261859. Haematologica. 2021. PMID: 32675221 Free PMC article.
Potential and emerging therapeutics for HHT.
Eswaran H, Kasthuri RS. Eswaran H, et al. Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):724-727. doi: 10.1182/hematology.2024000675. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644056 Free PMC article. Review.
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia.
Thompson KP, Sykes J, Chandakkar P, Marambaud P, Vozoris NT, Marchuk DA, Faughnan ME. Thompson KP, et al. Orphanet J Rare Dis. 2022 Nov 7;17(1):405. doi: 10.1186/s13023-022-02539-8. Orphanet J Rare Dis. 2022. PMID: 36344987 Free PMC article. Clinical Trial.
Integration of clinical parameters, genotype and epistaxis severity score to guide treatment for hereditary hemorrhagic telangiectasia associated bleeding.
Beckman JD, Li Q, Hester ST, Leitner O, Smith KL, Kasthuri RS. Beckman JD, et al. Orphanet J Rare Dis. 2020 Jul 13;15(1):185. doi: 10.1186/s13023-020-01453-1. Orphanet J Rare Dis. 2020. PMID: 32660636 Free PMC article.

See all "Cited by" articles

References

1. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Journal of medical genetics. 2011;48(2):73–87. - PubMed
1. Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. Journal of internal medicine. 1999;245(1):31–39. - PubMed
1. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) American journal of medical genetics. 2000;91(1):66–67. - PubMed
1. Grondin MA, Ruivard M, Perreve A, et al. Prevalence of iron deficiency and health-related quality of life among female students. Journal of the American College of Nutrition. 2008;27(2):337–341. - PubMed
1. Patterson AJ, Brown WJ, Powers JR, Roberts DC. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women’s Health. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2000;9(5):491–497. - PubMed

Publication types

Actions

Grants and funding

U54 NS065705/NS/NINDS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

[1] Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Journal of medical genetics. 2011;48(2):73–87. - PubMed

[2] Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. Journal of medical genetics. 2011;48(2):73–87. - PubMed

[3] Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. Journal of internal medicine. 1999;245(1):31–39. - PubMed

[4] Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. Journal of internal medicine. 1999;245(1):31–39. - PubMed

[5] Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) American journal of medical genetics. 2000;91(1):66–67. - PubMed

[6] Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) American journal of medical genetics. 2000;91(1):66–67. - PubMed

[7] Grondin MA, Ruivard M, Perreve A, et al. Prevalence of iron deficiency and health-related quality of life among female students. Journal of the American College of Nutrition. 2008;27(2):337–341. - PubMed

[8] Grondin MA, Ruivard M, Perreve A, et al. Prevalence of iron deficiency and health-related quality of life among female students. Journal of the American College of Nutrition. 2008;27(2):337–341. - PubMed

[9] Patterson AJ, Brown WJ, Powers JR, Roberts DC. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women’s Health. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2000;9(5):491–497. - PubMed

[10] Patterson AJ, Brown WJ, Powers JR, Roberts DC. Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women’s Health. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2000;9(5):491–497. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia

Collaborators

Affiliations

Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia

Authors

Collaborators

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Conflict of interest statement

Similar articles

Cited by

References

Publication types

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources